Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
24,906,977
-
Share change
-
+197,748
-
Total reported value
-
$3,080,532,328
-
Put/Call ratio
-
182%
-
Price per share
-
$122.72
-
Number of holders
-
288
-
Value change
-
+$36,671,638
-
Number of buys
-
107
-
Number of sells
-
128
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q2 2020
As of 30 Jun 2020,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
288 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,906,977 shares.
The largest 10 holders included
Capital Research Global Investors, FRANKLIN RESOURCES INC, Capital World Investors, JANUS HENDERSON GROUP PLC, CANADA PENSION PLAN INVESTMENT BOARD, CITADEL ADVISORS LLC, FEDERATED HERMES, INC., MORGAN STANLEY, FRED ALGER MANAGEMENT, LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
288
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.